Inhaled corticosteroids: first do no harmBMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e8204 (Published 20 December 2012) Cite this as: BMJ 2012;345:e8204
- Vincent H F Mak, consultant physician1
- On behalf of the NHS London Respiratory Team Programme Board
- 1Central Middlesex Hospital, London NW10 7NS, UK
Mackenzie highlights the lack of guidance on use of inhaled corticosteroids (ICS) and risk of adrenal suppression.1 The Medicines and Healthcare Products Regulatory Agency recommends issuing a steroid treatment card,2 but there is concern that this may alarm patients and reduce adherence. There is also no consensus on what constitutes a high dose.
High potency combination inhalers (ICS …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial